Anna Rigazio

发表

Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice

David Price, D. Price, Andrew M. Wilson, 2016, Journal of asthma and allergy.

Historical cohort study examining comparative effectiveness of albuterol inhalers with and without integrated dose counter for patients with asthma or chronic obstructive pulmonary disease

D. Price, T. Ferro, Anna Rigazio, 2016, Journal of asthma and allergy.

Erratum: Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study

D. Price, M. Miravitlles, G. Brusselle, 2017, npj Primary Care Respiratory Medicine.

Blood eosinophilia and the number of exacerbations in COPD patients

D. Postma, I. Pavord, D. Price, 2014 .

Inappropriate prescriptions following initial COPD diagnosis

D. Price, N. Freemantle, M. Miravitlles, 2013 .

Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.

Mike Thomas, Ian D Pavord, Jonathan D Campbell, 2015, The Lancet. Respiratory medicine.

RAISED BLOOD EOSINOPHIL LEVELS AS AN INDICATOR OF PROSPECTIVE ASTHMA OUTCOMES

Jonathan D. Campbell, I. Pavord, D. Price, 2013 .

Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study

D. Price, M. Miravitlles, G. Brusselle, 2016, npj Primary Care Respiratory Medicine.

Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice

D. Price, Andrew M. Wilson, A. Chisholm, 2016, Journal of asthma and allergy.